🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
TYPE / DESIGN STUDY: Clinical trial phase II / III, randomized, double-blin...
Status
Unknown
Location
• Unidade de Ensaios Clínicos para Imunobiológicos/Instituto de Tecnologia em Imunobiológicos de Bio-Manguinhos/Fiocruz
Start Date
2018-09-25
Trial ID
NCT02858570
Treatments Being Tested
The primary objective was to evaluate the persistence of bactericidal antib...
Status
Completed
Location
Alabama Clinical Therapeutics 806 St. Vincent's Drive, Suite 615
Start Date
2010-07
Trial ID
NCT01148017
Treatments Being Tested
The proposed study is aimed at assessing the safety and immunogenicity of r...
Status
Completed
Location
Site 55 - Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)
Start Date
2011-04
Trial ID
NCT01339923
The purpose/aim of this study is to assess the safety and antibody response...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-12-08
Trial ID
NCT02986854
The purpose of the study was to evaluate the immunogenicity and describe th...
Status
Completed
Location
Investigational Site
Start Date
2017-02-17
Trial ID
NCT03077438
In this extension study, V59P20E1, the sponsor was planning to assess 5-yea...
Status
Completed
Location
82 Children s Inv Research Prgm (ChIRP) 2900 Medical Center Parkway, Ste. 300
Start Date
2013-05
Trial ID
NCT01823536
Treatments Being Tested
The purpose of this study was to compare the immunogenicity and describe th...
Status
Completed
Location
Birmingham Pediatric Associates Site Number : 8400026
Start Date
2018-04-25
Trial ID
NCT03537508
Primary Objective: 1. To describe the vaccine seroprotection (antibody tit...
Status
Completed
Location
Investigational Site Number :4840001
Start Date
2018-10-17
Trial ID
NCT03630705
Treatments Being Tested
This is a global Phase 3 study to evaluate the safety and effectiveness of ...
Status
Completed
Location
The University of Alabama at Birmingham Hosptial Outreach Lab
Start Date
2019-07-18
Trial ID
NCT04006457
The purpose of the study was to evaluate the immunogenicity and describe th...
Status
Completed
Location
Multiple Locations
Start Date
2014-07-22
Trial ID
NCT02199691
Treatments Being Tested